\nStart-up-ul de biotehnologie The Cat Health Company (TCHC), care dezvolt\u0103 terapii pentru cre\u015fterea longevit\u0103\u0163ii felinelor, a ob\u0163inut o nou\u0103 rund\u0103 de finan\u0163are \u00een valoare de 1,2 milioane de dolari. Runda vine la aproximativ un an dup\u0103 ce compania a atras o prim\u0103 finan\u0163are pre-seed de 500.000 de euro, condus\u0103 de fondul de investi\u0163ii Early Game Ventures.<\/p>\n
\nNoua rund\u0103, de tip SAFE (Simple Agreement for Future Equity), a fost sus\u0163inut\u0103 de investitori specializa\u0163i \u00een domeniul longevit\u0103\u0163ii, precum fondul Active Aging & Longevity Fund II al Portfolia, 100 Plus Capital al Soniei Arrison \u015fi Alex Zhavoronkov, fondatorul unicornului farmaceutic Insilico Medicine. Early Game Ventures, primul investitor al start-up-ului, a participat de asemenea la rund\u0103.<\/p>\n
\nFinan\u0163area a fost atras\u0103 pe fondul unor rezultate intermediare \u00eencurajatoare din studiile clinice ale companiei, care au validat abordarea \u015fi portofoliul de terapii.<\/p>\n
\n\u201eAceasta este mai mult dec\u00e2t o simpl\u0103 investi\u0163ie; este un vot de \u00eencredere \u00een misiunea noastr\u0103 de a aduce solu\u0163ii reale de longevitate pentru domeniul veterinar\u201d, a declarat Alex Vod\u0103, CEO al The Cat Health Company. Alex B\u0103ci\u0163a, COO, a ad\u0103ugat: \u201eCu aceast\u0103 finan\u0163are, vom accelera cercetarea clinic\u0103, vom dezvolta noi terapii \u015fi, de asemenea, ne vom extinde echipa pentru a ne asigura c\u0103 putem veni pe pia\u0163\u0103 c\u00e2t mai repede cu aceste terapii care prelungesc via\u0163a pisicilor.\u201d<\/p>\n
\nFondat \u00een 2021 de Alex Vod\u0103 \u015fi Alex B\u0103ci\u0163a, start-up-ul a creat o platform\u0103 computa\u0163ional\u0103 care prezice eficacitatea unor terapii pentru bolile care apar la pisici odat\u0103 cu \u00eemb\u0103tr\u00e2nirea. Anul trecut, compania anun\u0163a c\u0103 testeaz\u0103 \u015fapte terapii diferite, cu a\u015fteptarea ca trei sau patru dintre ele s\u0103 ajung\u0103 \u00een stadiul final al procesului de aprobare.<\/p>\n
\nModelul de business al companiei vizeaz\u0103 patentarea moleculelor \u015fi terapiilor dezvoltate, care ulterior pot fi licen\u0163iate c\u0103tre companii farmaceutice mari pentru distribu\u0163ia \u00een mas\u0103. \u201ePractic, ce urm\u0103rim este o extensie de via\u0163\u0103 semnificativ\u0103 \u015fi un patent asupra moleculelor respective sau terapiilor respective, care dup\u0103 poate fi licen\u0163iat companiilor farmaceutice mai mari ce se pot ocupa de distribu\u0163ie \u00een mas\u0103, av\u00e2nd deja infrastructura necesar\u0103 \u015fi permi\u0163\u00e2ndu-ne nou\u0103 s\u0103 continu\u0103m s\u0103 facem ce \u015ftim cel mai bine: cercetare \u015fi dezvoltare \u00een direc\u0163ia de noi terapii, de noi patente”, explica anul trecut Alex B\u0103ci\u0163a \u00een cadrul emisiunii ZF IT Generation.<\/p>\n
\nCompania colaboreaz\u0103 cu clinici veterinare \u015fi laboratoare din Rom\u00e2nia \u015fi din str\u0103in\u0103tate, inclusiv SUA, pentru a derula testele clinice. Principalele pie\u0163e vizate sunt cele din America de Nord \u015fi Europa.<\/p>\n
\nPe baza noilor date clinice, care urmeaz\u0103 s\u0103 fie publicate \u00een cur\u00e2nd, The Cat Health Company \u0163inte\u015fte ob\u0163inerea aprob\u0103rilor din partea autorit\u0103\u0163ilor de reglementare \u00eencep\u00e2nd cu anul 2026.<\/p>\n","protected":false},"excerpt":{"rendered":"
Start-up-ul de biotehnologie The Cat Health Company (TCHC), care dezvolt\u0103 terapii pentru cre\u015fterea longevit\u0103\u0163ii felinelor, a ob\u0163inut o nou\u0103 rund\u0103 de finan\u0163are \u00een valoare de 1,2 milioane de dolari. Runda vine la aproximativ un an dup\u0103 ce compania a atras o prim\u0103 finan\u0163are pre-seed de 500.000 de euro, condus\u0103 de fondul de investi\u0163ii Early Game Ventures.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[472,7903,26662,22258,16124,11520,61408,231],"class_list":["post-240780","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-finantare","tag-fond-de-investitii","tag-longevitate","tag-pisica","tag-prelungire","tag-start-up","tag-the-cat-health-company","tag-viata"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/240780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=240780"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/240780\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=240780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=240780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=240780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}